Ch3rity registration number.. L165956 COST OF CANCER TRUSTEES. REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 CSW Accountancy Ltd
Cost of Cancer Contents P•ge Trustees, Report Independent Examiner's Report Statement of Flnancial Activitles Statement of Financi31 Position Notes to the Financial Statements 8-11
Cost of Cancer Trustees. Report For The Year Ended 31 December 2025 The trustees present their report and the financial Statements for the year ended 31 December 2025. Obje¢tive$ and Activities Alm$ and Objective$ The objective of the charlty is the relief or the financial har¢shlp among people suffering from cancer through the provision ofgrnts. The Trustees are aware of the Charity Commission Guidance on public benefit and therefo look to ensure their activities and grants provided meet this guidance together with the objectives Set out in the Trust Deed. During 2025, the charity continued to see significant demand for financial assistance from people undergoing cancer treatment. The ongoing pressures on household finances. combined with the financial impact that a cancer diagnosis and treatment can have on individua15 and familie5, rneans that the support provided by C05t of Cancer retnains as important a5 ever. A key objective carrled forward from the previous year was to increase the amount of financial support belng distrlbuted. The charity had built up reserves partly as a result of difficulties processing the Increasing number of applications received and was therefore keen to reduce the walting Ilst and ensure that available funds were being used to support those for whom the ch3rity was established. Signlficant progress was made during 2025, wlth both the number of famllies helpe¢ and the value of grants awarde¢ Increasing substant1311y compared with the previous year. Fundraising nevertheless remains challenging. The charity continues to recognise that changes in people's financial circumstances and the cost of living have affected both Individual donations and participation In fundraising activities. Developing relationships with businesses and sponsors therefo remains an irnportant part of the charity's strategyi alongside encouraging individuals and supporter5 to organise events and fundraising artivities. The charity a150 continue5 to Use social media to raise awareness of its work, fundraising activities and the support available to people undergoing cancer treatment. The monthly lottery continues to provide a regular source of income for the charityi although attracting new rnembers remalns an ongolng objective. Public Benefit The trustees confirm that they have complied with the requirements of Sertion 17 of the Charities Act 2011 to have due regard to the Charity Commission's guidance on public benefit. Achievements and Performance Main Achievements During 2025, income from donations and gifts was £1,315, with a further £4,287 received through Gift Aid, giving total donatlons and legacy income of E5,602. Fundraising event5 generated £14,124 during the year, with 5pon50r5hip5 and Social lotterie5 providing a further £2,662. Income from other trading activities was therefore E16,786. Including incorne frotn charitable artivities of £288 investrnent incorne of £1,347, the charity'5 total income for the year Was £24,023. Most Importantly, durlng 2025 the charity provlded flnanclal assistance totalling £22,871 to 15 familles affected L>y cancer. This represents a substantlal Increase in the level of dlrecr charltable support provlded during the year and Is a particularly positive development ror the charlty. One of the objectives identified in the previous year's Trustee Report was to reduce the W31ting list and make greater use of the funds that had accumulated in reserves. .CONTINUED Page I
Cost of Cancer Trustees. Report (continued) For The Year Ended 31 December 2025 Maln A¢hlevement$ - continued The signlficant Increase in both the number of famllies helped and the value of grants awarded durlng 2025 demonstrates re31 progress tOW3rds this objective and means that the charlty has been 3ble to provlde me3ningful fin3nci31 assistance to considerably more people during a very difficult period In their lives. Demand for support MaInS high, and the Trustees continue to recognise the importance of balancing the need to help as many families as possible with ensuring that grants are awarded fairly, appropriately and at a level that is sustainable for the charity. Cost of Cancer continues to be operated on a voluntary ba515 and does not employ any staff. This enables the charity to maintain a strong focus on directing its available resources towards its charitable purpose. Financial Review Financial Position Total income for the year was £24,023, compared with £29,668 in 2024. Total expendlture Increased to £29,219, compared wlth £13,723 In the prevlous year. Thls Increase was prlncipally due to the substantially greater level of grants awarded to individuals during 2025. As a SUIt, the charity ocorded a deficit OF E5,196 for the year, compared with a surplus of £15,945 in 2024. The Trustees regard this use of accumulated funds as consistent with the charity's objettives and the intention expressed in the pViouS year's report to Increas& grant giving and reduce the level of surplus serVeS. The deficit during the year therefore principally reflects the charity putting more of Its 3vai13ble funds to work in directly supporting people affected by Cancer. At 31 December 2025, the charity held £67,888 in cash at bank and in hand. After Credito of £840, total unrestricted funds and net assets were £67,048, compared with £72,244 at the end of 2024. Reserves Policv The charity's reserves policy is to maintain sufficient reserves to enable it to continue its activities and meet anticipated comtnitments. Although reserves remain above the level required for normal operating purposes, the Trustees are mindful or the continuing high demand for financial support and Intend to conrinue using the charlty's resources to increase Its charitable impact while maintaining an appropriate financial reserve. FUTURE PLANS The charity'5 principal al remain5 to 1CaSe the number of people and fallieS It Is able to 5UPPOrt. Following the substantial increase in grant5 awarded during 2025, the Tru5tee5 intend to continue working through applications as efficiently as ptsssible while ensuring that the charity's grant-making process remains fair and sustainable. Fundraising will remaln essential if thls Increased level of charitable support is to continue. The charity therefore intends to.. continue developing relationships with businesse5 and sponsors,. encourage more individuals and supporters to organise fundraising activities. increase awareness of Cost of Cancer through social rnedia and other channels,. continue promoting the rnonthly lottery and seek to Increase participation,. organise and 5UPPOrt fundraising events., and continue lSing awareness of the financial a55iStance available to people underyoing cancer tatMent. The Tru5tee5 will continue to OnItOr the level of reserves alongside the nurnber and value of applicatlOn5 received, with the aim of ensuring that funds raised a used effectively tt> pmvide meaningful financial assistance to those affected by cancer. Structure. Governance and Management Page 2
Cost of Cancer Trustees. Report (continued} For The Year Ended 31 December 2025 Goveming Document Goveming t>o¢ument The charity is controlled by its goveming document, a Deed of Trust, and constitutes an unincorporated charity. Key De¢i$ion$ All Trustees are responsible for decision making in olation to the gont-giving process. If any Trustee knows an individual who opplies for a55i5tsnce, that Trustee must abstain from the decision-making process in order to ensufft that applications are considered fairly and irnpartially. Trustee Appolntments When appointing a new Trustee, the existing Trustees will be consulted. Suitable individuals may then be approached to assist the charity as Trustees, following which a confirmation meeting will be held with all Trustees. Reference and Admlnlstratlve Detslls Trustees Mrs Nicola Moss Mrs Emma Thornas Mrs Catherine Bamard Charity Number 1165956 Prlnclpal Addre$$ Unit 8 Green Court Village Farm Industrlal Estate Pyle Bridgend CF33 6BN Endependent Examiner Carl West ACA CSW Accountancy Ltd ICAEW 43 Brynymor Road Gowerton Swansea SA4 3EY Page 3
Cost of Cancer Trustees. Report (continued} For The Year Ended 31 December 2025 The trustees, report was approved by the board of trustees and signed on its behalf by.. Mrs Nicola Moss Trustee 0810912026 Page 4
Cost of Cancer Independent Examiner's Report to the Trustees of Cost of Cancer For The Year Ended 31 December 2025 I report to the trustees on my examination of the account5 of Cost of Cancer Ithe Trustl for the year ended 31 December 2025. Responslbllltles and Basls of Report As the charity trustees or the Trust you are responslble for the preparatlon of the accounts in accordance with the requirements of the Charities Act 2011 I-the Act"). I report in respect of my examination of the Trust's accounts carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 1451Sllbl of the Act. Independent Examiner's Statement I have completed my exarnination. I confirm that no material tnatters have come to rny attention in connection with the examination giving rne cause to believe that in any rnaterial Spect.. accounting records were not kept in respect of the Trust as required by section 130 of the Act., or 2. the accounts do not accord wlth those cOrdS. or 3. the accounts do not comply with the applicable requirements concerning the form and contents of accounts set out in the Charities IAccountS 3nd Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair view, which Is not 3 matter considered as p3rt of an Independent examination. I have no concerns and have come across no other marters in connection with the examlnation to whlch attention should be dWrn In this report In order to enable a proper understanding of the accounts to be reached. Carl West ACA 0810912026 43 Brynymor Road Gowerton Swansea SA4 3EY Page 5
Cost of Cancer Statement of Financial Activities For The Year Ended 31 December 2025 2025 2024 Unrestrlcted Unrestrlcted funds funds Notes INCOME AND ENDOWMENTS FROM: Donations and legacies Charitable activitles.. 5,602 4.389 Charitable activities Other trading activities Investments 288 16,786 1,347 34 23,243 2,002 24,023 29,668 EXPENDITURE ON: Raising funds Charitable activities.. 16,3481 15,7811 Charitable activities 122,8711 17,9421 129,2191 113,7231 NET (EXPENDITURE)IINCOME 15,1961 15,945 NET MOVEMENT IN FUNDS 15,1961 15,945 RECONCILIATION OF FUNDS: Total funds brought forward 72,244 56,299 TOTAL FUNDS CARRIED FORWARD 12 67,048 72,244 The notes on pages 8 to 11 form part of these financial statements. Page 6
Cost of Cancer Statement of Financial Position As At 31 December 2025 2025 2024 Unrestrlcted funds Total funds Notes CURRENT ASSETS Debtors io 300 Cash at bank and in hand 67,888 73,085 67,888 73,385 Creditors: Amounts Falling Due Within One Year 18401 11.1411 NET CURRENT ASSETS (LIABILITIES) 67,048 72,244 TOTAL A$Ss LESS CURRENT LIABILITIES 67,048 72,244 NET ASSETS 67,048 72,244 FUNDS OF THE CHARITY Unrestricted Funds 67.048 72.244 TOTAL FUNDS 12 67,048 72.244 On behalf of the board Mrs Nicola Moss Trustee 0810912026 The notes on pages 8 to 11 form part of these financial statements. Page 7
Cost of Cancer Notes to the Financial Statements For The Year Ended 31 December 2025 l. General Information C05t of Cancer is an unincorporated charity rIsted with the Charity Comrnission, registered charity number 1165956. The principal address is Unit 8 Green Court, Village Farm Industrial Estate, Pyle, Bridgend, CF33 6BN. Accounting Policies 2. 1. Basis of Prepar•tion of Firtancial St•tements The financial statements have been prepared in accordance with the Charities SORP IFRS 1021 "Accounting and Reporting by Charifies.. Statement OF Recommended Practice applitable to tharities preparing their atcounts in accordance with the Financial Reporting Standard applicabl& in the UK and Republic of Ireland IFRS 1021 (effective I january 20191. Financi31 Reporting Standard 102 "The Financi31 Reporting Standard applicable In the UK and Republic of Ireland and the Charitie5 Act 2011. The charity is a Public Benefit Entity as defined by FRS 102. 2.2. Incoming Resources All incorning SOurceS are included in the statement of financial activities when entitlement has passed to the charity,. it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income.. • income from donations or grants Is recognlsed when there is evidence of eniitlement to the glft, receipt is probable and Its amount can be measured rellably. legacy Income Is recognised when receipt Is probable and entitlement is established. Income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estirnated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contrlbution of general volunteers. Income from contracts for the supply of services is recognised with the delivery of the contCted service. This is classified as unrestricted funds unless there is a contractual wuirement for it to be spent on a particular purpose and returned if unspent, in which case it may be rarded as restricted. 2.3. Resources Expended Expenditure is recognised on an accruals ba515 as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, is cla55ified under heading5 of the statement of financial activitie5 to which it lateS.. expenditure on raising funds Includes the costs of all fUndlSIng actlvlties, events, non charitable trading activitles, and the sale of donated goods. expenditure on charitable activities includes all costs Incurred by a charity in undertaking activities that further Its charitable aims for the benefit of it5 beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities. • other expenditure includes all expendlture that Is nelther related to raising funds for the charlty nor part of its expendlture on charitable activitles. All costs are allocated to expenditure categories reflecting the use OF the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable. justifiable and consistent basis. 2.4. Cash and Cash Equlvalents Cash and cash equivalents are basic financial assets and include cash In hand and deposits held at call with banks, other short-terrn highly liquid Investments that mature in no more than three rnonths frorn the date of acquisition and are readily convertible to a known arnount of cash with insignificant risk of change in value. and bank overdrafts. 3. Income from Donations and Legacies 2025 2024 Unrestricted Unre$trirte funds funds Oonation5 and gifts Gift aid 1,315 4.287 1,635 2,754 5,602 4,389 Page 8
Cost of Cancer Notes to the Financial Statements (continued) For The Year Ended 31 December 2025 4. Income from Other Trading Activitie5 2025 2024 Unrestrlcted Unrestrlcted funds funds FUndlsIng events Sponsorships 150cial lotteries 14,124 2,662 20,559 2,684 16,786 23.243 Investment Income 2025 2024 Unrestricted Unrestrirted funds funds Bank interest receivable 1.347 2.002 Analysls of Expendlture 2025 Artivities undertaken dlrectly Grant funding of actlvltle$ Support costs (see note 71 Totsl Raising funds Charitable activities 5.500 848 6.348 22.871 22,871 5,500 22,871 848 29,219 2024 Activities undertaken directly Grant funding of activities Support costs (see note 71 Total Raising funds Charitable activitles 4,460 1,321 5,781 7,942 7,942 4,460 7,942 1,321 13,723 Page 9
Cost of Cancer Notes to the Financial Statements (continued) For The Year Ended 31 December 2025 7. Support Costs 2025 Ralslng funds Interest payable Governance costs 840 848 2024 Raising fund$ Interest payable Governance costs 1,320 1,321 8. Independent Examiner's Remuneration 2025 2024 Independent examination of the financial statements 840 1,320 9. Average Number of Employee$ Average number of ernployees during the year was.. NIL12024'. 1 10. Debtors 2025 2024 Due within one year other debtors 300 11. Credltors: Amounts Falllng Due Wlthln One Year 2025 2024 Trade creditors Accrua15 deferred income 840 1,140 840 1.141 Page 10
Cost of Cancer Notes to the Financial Statements (continued) For The Year Ended 31 December 2025 12. Movement in Funds Asati January Asat31 December 2025 Income Expenditure 2025 Unrestricted funds General.. Gener31 unrestricted fund 72,244 24,023 129.2191 67,048 Totsl funds 72,244 24,023 129,2191 67.048 A$atl J•nu•ry 2024 A$at31 December 2024 Income Expendlture Unrestricted funds General.. General unrestricted fund 56,299 29,668 113,7231 72,244 Total funds 56,299 29,668 113.7231 72,244 13. Tran$artion$ with Tru$tee$ During the year the expenses reirnbur5ed to the trustees or paid directly to third parties were as follows.. 2025 2024 14. Related Party Disclosures Page 11